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Abstract
Purpose—Diet may influence the development of ovarian cancer. While inflammation has been 
shown to play an important etiologic role on ovarian carcinogenesis, little is known about the 
influence of the inflammatory potential of food consumption.
Methods—Data from a case-control study conducted in New Jersey (USA) were used to estimate 
the relation between a dietary inflammatory index (DII) and the risk of ovarian cancer. The study 
consisted of 205 cases with incident, histologically confirmed ovarian cancer, and 390 controls 
identified by random digit dialing, based on CMS (Centers for Medicare and Medicaid Service) 
lists, and area sampling. Computation of the DII was based on the intake of selected dietary factors 
assessed by a validated Food Frequency Questionnaire (FFQ). Logistic regression models were fit 
to estimate odds ratios (ORs) and 95% confidence intervals (CI) adjusted for potential covariates.
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Results—Although there was no significant association observed in pre and peri-menopausal 
women, a significant association was observed between the most pro-inflammatory DII scores and 
ovarian cancer among post-menopausal women (ORQuartile4vs1=1.89, 95 % CI, 1.02–3.52; 
Ptrend=0.03).
Conclusion—Our finding suggests that a pro-inflammatory diet may increase ovarian cancer 
risk among post-menopausal women, and warrants further study to confirm this association.
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INTRODUCTION
Among gynecological cancers ovarian cancer has the highest mortality rates, with dismal 
five-year survival rates (46% for all stages combined; 28% for advanced stage, in which 
62% of the cases are diagnosed) [1]. The American Cancer Society estimates 22,440 new 
cases and 14,080 deaths from ovarian cancer in the United States in 2017 [1]. Risk factors 
for ovarian cancer include increasing age, family history of the disease (specifically 
mutations in BRCA1 and BRCA2 genes), obesity and nulliparity, while oral contraceptive 
use, higher parity, and tubal ligation have been shown to reduce risk [2,3]. Several studies 
have been conducted exploring the association between dietary factors and ovarian cancer 
with inconsistent results [4]. While there is growing evidence linking inflammation to 
ovarian carcinogenesis [5,6], to date there have been only two studies that have explored the 
role that inflammatory potential of diet plays in ovarian cancer risk [7,8]; one of them was 
conducted exclusively among African American women [7] and the other was among Italian 
women [8].
A literature-derived, population-based dietary inflammatory index (DII) was recently 
developed to assess the inflammatory potential of an individual’s diet [9]. A pro-
inflammatory diet is high in foods rich in saturated fat and carbohydrates, and low in foods 
rich in poly-unsaturated fatty acids, flavonoids, and other dietary components, include a 
variety of vitamins and minerals [10]. The DII has been validated in a variety of longitudinal 
and cross-sectional studies with various inflammatory markers, including C-reactive protein 
[11,12], interleukin-6 [13,14], and tumor necrosis factor-α [14]. The DII has been 
associated with risk of colorectal cancer in case-control studies in Spain and Italy [15,16] 
and in 3 cohort studies in the USA [10,17,18], and risk of pancreatic, prostate and 
endometrial cancers in case-control studies in Italy [19–22]. In this study we evaluate the 
impact of a pro-inflammatory diet, as indicated by a high DII on ovarian cancer risk in a 
New Jersey population.
METHODS
We evaluated the association between DII and ovarian cancer in the NJ Ovarian Cancer 
Study, described in detail elsewhere [23–26]. In brief, our study included 205 newly 
diagnosed, histologically confirmed cases of invasive epithelial ovarian cancer identified 
through rapid case ascertainment implemented by the New Jersey State Cancer Registry 
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(NJSCR) staff. Women older than 21 years, able to understand English or Spanish, and 
residing in one of six New Jersey counties (Bergen, Essex, Hudson, Middlesex, Morris, and 
Union) were eligible to participate. Controls (n=390) had the same eligibility criteria as the 
cases except that women with a history of hysterectomy and/or bilateral oophorectomy were 
excluded from the analysis. Controls were identified through random digit dialing for 
women <65 years of age and through random selection of Center for Medicare and Medicaid 
Services lists, complemented with area sampling for women ≥65 years of age.
After obtaining informed consent, a telephone interview was scheduled, during which 
information was collected on established and suspected risk factors for ovarian cancer as 
well as on demographic characteristics. Dietary data were collected using the Block 98.2 
Food Frequency Questionnaire (FFQ), which included questions about usual intake during 
six months before diagnosis for cases or on the date of interview for controls. The Block 
98.2 FFQ (NutritionQuest, Berkeley, CA) was developed from the National Health and 
Nutrition Examination Survey III dietary recall data includes 110 food and beverage items 
and queries on frequency and portion size for each item. Pictures were provided to enhance 
accuracy of estimation of portion size.
Dietary Inflammatory Index (DII)
FFQ-derived dietary data were used to calculate the DII for each subject. A complete 
description of the DII is available elsewhere [9]. Briefly, dietary data were first linked to a 
regionally representative global database that provided a robust estimate of the mean and the 
standard deviation for each food parameter included in the DII. These parameters then 
became the multipliers to express an individual’s exposure relative to the “standard global 
mean” as a z-score. This was achieved by subtracting the “standard global mean” from the 
amount reported and dividing this value by the standard deviation. To minimize the effect of 
“right skewing,” this value was then converted to a centered (on zero) percentile score (by 
taking the percentile ranking of the z-score, multiplying by 2 and subtracting 1). The 
centered percentile score for each food parameter for each subject was then multiplied by 
the corresponding food parameter effect score in order to obtain a food parameter-specific 
DII score. All of the food parameter-specific DII scores were then summed to create the 
overall DII score for each subject. The DII was calculated from foods and supplements. To 
control for total energy intake, the DII was calculated per 1,000 calories of food consumed, 
which requires using the energy-standardized version of the global database. This study had 
data on 29 of the 45 food parameters studied for DII development; food parameters that are 
available and that are unavailable in this study are shown in Appendix 1. Steps involved in 
calculating the DII score are described in Figure 1.
Statistical Analyses
DII scores were analyzed by quartiles of exposure in controls. Body mass index (BMI) was 
calculated as weight (in kg) divided by height (in meters) squared and was categorized as: 
underweight (<18.5 kg/m2); normal weight (BMI 18.5– 24.9 kg/m2); overweight (25.0 
kg/m2 ≤ BMI <30.0 kg/m2); and obese (BMI ≥ 30.0 kg/m2). Age-adjusted means were 
calculated for cases and controls for pro-inflammatory food parameters (protein, saturated 
fat, cholesterol and carbohydrates) and anti-inflammatory food parameters (vitamin B1, 
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Niacin, Folate, Vitamin C and dietary fiber) and compared using analysis of covariance. 
Odds ratios (OR) and the corresponding 95% confidence intervals (95% CI) were estimated 
using logistic regression models, adjusting only for age as a continuous variable and 
additionally adjusting for education, race, age at menarche, menopausal status, parity, oral 
contraceptive use, hormone therapy use, tubal ligation, BMI categories, physical activity (in 
metabolic equivalents (or METs) for reported average hours per week of strenuous or 
moderate recreational activities), and smoking status. Effect modification by menopausal 
status and BMI categories was evaluated. Testing for heterogeneity was carried out by 
including the interaction terms in the model. Tests for trend were computed by assigning the 
median value to each quartile. All analyses were completed using SAS® version 9.3 (SAS 
Institute, Cary NC).
RESULTS
Participants in the New Jersey Ovarian Cancer Study were primarily White (87.3% of cases 
and 88.4% of controls) and approximately 25% of cases and controls had a graduate school 
education [23] (data not shown). Mean values of selected pro- and anti-inflammatory food 
parameters for cases and controls are shown in Table 1. Mean DII value among cases was 
1.1 (SD= ±0.2) and among controls was 0.8 (SD=±0.1) indicating a slightly more pro-
inflammatory diet for cases (p=0.18). For pro-inflammatory food parameters, cases had 
slightly higher intakes of saturated fat and carbohydrates and for anti-inflammatory food 
parameters, cases had significantly lower intakes of niacin and slightly lower levels of 
vitamin B1, folate, vitamin C and dietary fiber compared to controls.
OR and 95% CI of ovarian cancer according to quartiles of DII are shown in Table 2. No 
significant associations were observed between DII and overall ovarian cancer (i.e., across 
all ages). In age-adjusted models results suggestive of a positive association were observed 
for DII with ovarian cancer (ORQuartile4vs 1= 1.38, CI= 0.85–2.26, Ptrend=0.27). Similarly, 
for multivariable analyses, suggestive positive associations were observed, with 
ORQuartile4vs 1 of 1.39 (95% CI=0.82–2.35, Ptrend=0.26). When stratified by menopausal 
status, a significant association was observed among post-menopausal women consuming 
the most pro-inflammatory diet (ORQuartile4vs1=1.89, 95 % CI, 1.02–3.52; Ptrend=0.03) 
(Table 3). P-value for interaction was nearly significant with menopausal status (P-
value=0.08). In analyses stratified by BMI, the association appeared to be stronger in 
overweight and obese women, but the confidence interval for both the categories included 
the null (p for interaction=0.46).
DISCUSSION
In this case-control study conducted in New Jersey, we found some evidence of elevated risk 
associated with higher DII only among postmenopausal women. No association with ovarian 
cancer was found in earlier reports in the same case-control study with the Healthy Eating 
Index or with total antioxidant capacity [24,25], while selenium from food sources reduced 
the risk [25] and there was suggestion of decreased risk with increased phytoestrogen 
consumption [23]. Results from other studies exploring dietary components that contribute 
to the DII score and ovarian cancer have been inconsistent. In the NIH-AARP cohort study, 
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sugar consumption was inversely associated with ovarian cancer [27], whereas no 
association was observed with sugar in this NJ case-control study [26] and in a cohort study 
conducted in Canada, glycemic index and carbohydrate were not associated while glycemic 
load increased risk of ovarian cancer [28]. In an Italian multicenter case-control study, fiber 
intake was associated with reduced the risk [29]. No association was observed with dietary 
phytoestrogens in two Australian case-control studies [30]. In relation to the DII, fiber has 
an anti-inflammatory effect score while simple carbohydrates have a pro-inflammatory 
effect score [9]. Though phytoestrogens, especially flavonoids have anti-inflammatory 
scores, data on flavonoids were not available in this study; hence, they could not be used for 
DII calculation. The DII has been shown to be associated with ovarian cancer in one study in 
Italy; subjects in the highest quartile of DII scores (i.e., with the most pro-inflammatory 
diets) had a higher risk of ovarian cancer compared to subjects in the lowest quartile (i.e., 
with an anti-inflammatory diet) (ORQuartile4vs1 1.47, 95% confidence interval, CI, 1.07, 
2.01; p trend = 0.009) [8]. Similarly, in a study conducted in the US African-American 
women consuming the most pro-inflammatory diet had a statistically significant increased 
ovarian cancer risk in comparison to the most anti-inflammatory diet (ORQuartile4/
Quartile1 3=31.72; 95% CI3=31.18–2.51) [7,8].
We did not observe significant association between DII and ovarian cancer among pre-
menopausal women, similar results were seen in the previous two studies [7,8]. The absence 
of an association between DII scores and ovarian cancer among pre-menopausal women in 
this study could be explained by the fact that there are strong hormonal and reproductive 
factors which play a more important role in the development of ovarian cancer at younger 
ages when the ovaries are fully functional [31,32]. By contrast, inflammation may represent 
relatively more important influences in in post-menopausal women. Furthermore, the pre-
menopausal group may have a different type of ovarian cancer that has developed secondary 
to germline alterations independent of any dietary factors. For example, women with 
germline BRCA1/2 deleterious mutations tend to develop ovarian and other cancers at an 
earlier age and thus are more likely to be pre-menopausal [33]. In contrast, the 
postmenopausal group may develop cancer as a result of somatic mutations that happen over 
time and as a response to environmental factors such as exposure to an inflammatory diet.
Certain limitations of this study should be noted. Our sample size was relatively small, 
which may have affected our statistical power to detect associations. Additionally, the study 
was subjected to the limitations of case–control studies, such as recall and selection biases. 
However, the distribution of risk factors such as parity, tubal ligation, and oral contraceptive 
use of cases and controls in this study [23], is similar to that reported in other studies 
[3]which gives us reassurance in the validity of our data. Another limitation is the use of the 
FFQ, which may lead to measurement error, even in healthy individuals [34,35] and may be 
associated with disease- differential reporting biases [36,37]. With respect to the DII, no 
information was available on 16 16 food parameters. DII calculated from the 29 available 
food parameters has not been validated with inflammatory markers, though we have found 
little drop off in predictability in other studies, such as the SEASONS Study [10] and the 
Women’s Health Initiative [17], which used essentially the same FFQ as in this study.
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In conclusion, our study provided suggestive evidence that a pro-inflammatory diet, as 
shown by higher DII scores, increased risk of ovarian cancer in postmenopausal women. 
However, this finding requires replication in larger studies, including prospective cohorts, 
which may provide more definite evidence regarding the possible role of diet-related 
inflammation on ovarian cancer etiology and possible effect modification by menopausal 
status and body mass index.
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Highlights
• Ovarian cancer has been linked to chronic inflammation and diet. Yet, the 
impact of an inflammatory diet on ovarian cancer risk is unclear.
• In this study, we assessed the association between dietary inflammation and 
risk for ovarian cancer.
• Proinflammatory diets (as indicated by dietary scores) are associated with 
increased ovarian cancer risk among post-menopausal women.
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Figure 1. 
Sequence of steps in creating the dietary inflammatory index in the New Jersey Ovarian 
cancer case-control study
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Table 1
Means for cases and controls for the Dietary Inflammatory Index (DII) and some of its components
Variablea Cases (n=205) Controls (n=390) P-value
Mean (SE) Mean (SE)
DII 1.1 (0.2) 0.8 (0.1) 0.18
Pro-inflammatory food parametersb
Protein (g) 41.3 (2.23) 42.5 (3.5) 0.27
Saturated fat (g) 13.2 (1.82) 12.9 (1.34) 0.72
Cholesterol (mg) 114.9 (3.6) 115.0 (2.6) 0.98
Carbohydrates(g) 122.6 (1.7) 119.8 (1.2) 0.17
Anti-inflammatory food parametersc
Vitamin B1 (mg) 0.78 (0.01) 0.80 (0.01) 0.26
Niacin (mg) 10.8 (0.20) 11.5 (0.14) 0.006
Folate (mcg) 221.5 (4.5) 222.5 (3.2) 0.86
Vitamin C (mg) 77.8 (3.0) 78.9 (2.1) 0.76
Dietary fiber (g) 9.9 (0.30) 10.4 (0.2) 0.16
a
Density measure calculated as daily intake in respective units per 1,000 kcal
bAs indicated by the positive inflammatory effect scores in the DII development manuscript (38)
cAs indicated by the negative inflammatory effect scores in the DII development manuscript (38)
Nutrition. Author manuscript; available in PMC 2019 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Shivappa et al. Page 12
Ta
bl
e 
2
O
dd
s r
at
io
s (
OR
) o
f o
v
ar
ia
n 
ca
nc
er
 a
nd
 c
or
re
sp
on
di
ng
 9
5%
 co
nf
id
en
ce
 in
te
rv
al
s (
CI
) f
or 
qu
art
ile
s o
f D
II 
am
on
g 2
05
 ca
ses
 an
d 3
90
 co
ntr
ols
. N
ew
 Je
rs
ey
,
 
20
04
–2
00
8.
D
II
 q
ua
rt
ile
s
P t
re
nd
<
 −
1.
28
−
1.
28
–0
.6
8
0.
69
–2
.2
4
>
2.
24
Ca
se
s/C
on
tro
ls
53
/9
8
44
/9
7
41
/9
8
67
/9
7
M
od
el
 1
b
1 
a
0.
84
 (0
.50
, 1
.41
)
0.
71
 (0
.42
, 1
.20
)
1.
38
 (0
.85
, 2
.26
)
0.
27
M
od
el
 2
c
1 
a
0.
86
 (0
.49
, 1
.49
)
0.
83
 (0
.47
, 1
.46
)
1.
39
 (0
.82
, 2
.35
)
0.
26
a R
ef
er
en
ce
 c
at
eg
or
y.
b M
od
el
 1
 a
dju
ste
d f
or 
ag
e
c M
od
el
 2
 a
dju
ste
d f
or 
ag
e (
co
nti
nu
ou
s),
 ed
uc
ati
on
 (h
igh
 sc
ho
ol 
or 
les
s, c
oll
eg
e,
 g
ra
du
at
e 
sc
ho
ol
), r
ac
e (
W
hit
e, 
Bl
ac
k, 
Ot
he
r, H
isp
an
ic
), a
ge
 at
 m
en
arc
he
 (c
on
tin
uo
us
), m
en
op
au
sal
 st
atu
s (
pre
-/p
eri
-
m
en
o
pa
us
al
, p
os
tm
en
op
au
sa
l),
 pa
rit
y (
0–
1, 
2, 
3–
4),
 or
al 
co
ntr
ac
ep
tiv
e 
u
se
 (e
v
er
,
 
n
ev
er
), H
T 
us
e (
ne
v
er
,
 
u
n
o
pp
os
ed
 e
str
og
en
 o
nl
y, 
an
y 
co
m
bi
ne
d 
H
T)
, tu
ba
l li
ga
tio
n 
(no
, y
es)
, B
M
I (
co
nti
nu
ou
s),
 sm
ok
ing
 
st
at
us
 (n
ev
er
,
 
pa
st,
 c
ur
re
nt
).
Nutrition. Author manuscript; available in PMC 2019 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Shivappa et al. Page 13
Ta
bl
e 
3
O
dd
s r
at
io
s (
OR
) o
f o
v
ar
ia
n 
ca
nc
er
 a
nd
 c
or
re
sp
on
di
ng
 9
5%
 co
nf
id
en
ce
 in
te
rv
al
s (
CI
) f
or 
qu
art
ile
s o
f D
II 
am
on
g 2
05
 ca
ses
 an
d 3
90
 co
ntr
ols
. N
ew
 Je
rs
ey
,
 
20
04
–2
00
8. C
as
es
/C
on
tr
o
ls
D
II
 q
ua
rt
ile
sa
P t
re
nd
P i
nt
er
ac
tio
n
<
 −
1.
28
−
1.
28
,0
.6
8
0.
69
,2
.2
4
>
2.
24
M
en
op
au
sa
l s
ta
tu
s
 
Pr
e/
Pe
ri
71
/4
9
1b
0.
62
 (0
.14
, 2
.67
)
0.
12
 (0
.03
, 0
.58
)
0.
74
 (0
.19
, 2
.84
)
0.
41
 
Po
st
-
13
4/
33
8
1b
0.
91
 (0
.47
, 1
.75
)
1.
30
 (0
.68
, 2
.52
)
1.
89
 (1
.02
, 3
.52
)
0.
03
0.
08
BM
I (
kg
/m
2 )
 
<
25
91
/1
80
1b
1.
29
 (0
.60
, 2
.81
)
1.
11
 (0
.47
, 2
.60
)
1.
29
 (0
.58
, 2
.86
)
0.
60
 
≥2
5
11
2/
20
3
1b
0.
57
 (0
.24
, 1
.31
)
0.
61
 (0
.27
, 1
.37
)
1.
60
 (0
.75
, 1
.37
)
0.
19
0.
46
a M
od
el
 a
dju
ste
d f
or 
ag
e (
co
nti
nu
ou
s),
 ed
uc
ati
on
 (h
igh
 sc
ho
ol 
or 
les
s, c
oll
eg
e,
 g
ra
du
at
e 
sc
ho
ol
), r
ac
e (
W
hit
e, 
Bl
ac
k, 
Ot
he
r, H
isp
an
ic
), a
ge
 at
 m
en
arc
he
 (c
on
tin
uo
us
), m
en
op
au
sal
 st
atu
s (
pre
me
no
pa
us
al,
 
po
stm
en
op
au
sa
l),
 pa
rit
y (
0–
1, 
2, 
3–
4),
 or
al 
co
ntr
ac
ep
tiv
e 
u
se
 (e
v
er
,
 
n
ev
er
), H
T 
us
e (
ne
v
er
,
 
u
n
o
pp
os
ed
 e
str
og
en
 o
nl
y, 
an
y 
co
m
bi
ne
d 
H
T)
, tu
ba
l li
ga
tio
n 
(no
, y
es)
, B
M
I (
co
nti
nu
ou
s),
 sm
ok
ing
 st
atu
s (
ne
v
er
,
 
pa
st,
 c
ur
re
nt
).
b R
ef
er
en
ce
 c
at
eg
or
y.
Nutrition. Author manuscript; available in PMC 2019 February 01.
